Thalidomide
Thalidomide targets to CRBN with IC50 of 8.5 nM. It can inhibit biosynthesis of TNF-α and has anti-angiogenic and immunosuppressive effects.

Trivial name | / |
Catalog Number | CSN12073 |
Alternative Name(s) | / |
Research Area | Cancer |
Molecular Formula | C13H10N2O4 |
CAS# | 50-35-1 |
Purity | ≥99% |
SMILES | O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC=C3)=O |
Size | 250mg |
Supplier Page | https://www.csnpharm.com/products/thalidomide.html |